Panbela Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Panbela Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer (NCT05254171) | Panbela Therapeutics, Inc. | 2022-08-08 |
| Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer (NCT03412799) | Panbela Therapeutics, Inc. | 2018-06-04 |
Track Panbela Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.